M&A Deal Summary

Tosoh Bioscience Acquires Semba Biosciences

On October 4, 2021, Tosoh Bioscience acquired life science company Semba Biosciences

Acquisition Highlights
  • This is Tosoh Bioscience’s 1st transaction in the Life Science sector.
  • This is Tosoh Bioscience’s 1st transaction in the United States.
  • This is Tosoh Bioscience’s 1st transaction in Wisconsin.

M&A Deal Summary

Date 2021-10-04
Target Semba Biosciences
Sector Life Science
Buyer(s) Tosoh Bioscience
Deal Type Add-on Acquisition

Target

Semba Biosciences

Madison, Wisconsin, United States
Semba Biosciences is a life science company that pioneered the development of multi-column chromatography (MCC) instrumentation and technology for downstream purification of biologics. Semba Biosciences was founded in 2005 and is based in Madison, Wisconsin.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Tosoh Bioscience

King of Prussia, Pennsylvania, United States

Category Company
Sector Medical Products
DESCRIPTION

Tosoh Bioscience is a provider of separation and purification products and technologies to the life sciences industry. Tosoh Bioscience offers pre-packed columns and bulk resins under the TSKgel, TOYOPEARL, and ToyoScreen brand names. Tosoh Bioscience is based in King of Prussia, Pennsylvania.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Wisconsin M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2021 M&A 1 of 1